Back to 
HBK Investments L.P.
HBK Investments L.P.
AR2
3 quarters
Position history for HBK Investments L.P.'s holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, HBK Investments held 3,486,602 shares of AR2 (Array Biopharma), worth $161.5M. HBK Investments' 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 1.4% of HBK Investments' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$982,000
Total Shares Change
-40,262
Quarter-by-Quarter History
Other major holders of AR2: Farallon Capital Management, L.L.C., Citadel Advisors LLC, Magnetar Financial LLC, Millennium Management LLC, Geode Capital Management, LLC